Sihuan Biological (000518.SZ) released its first quarter financial results, with a net loss attributable to shareholders of 15.9147 million yuan.

The Smart Financial News APP reports that Sihuan Pharmaceutical (000518.SZ) released its first quarter report for 2025. In the first quarter, the company achieved operating income of 43,841,700 yuan, a year-on-year decrease of 22.26%. The net loss attributable to shareholders of the listed company was 15,914,700 yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 18,566,000 yuan.